Treating cannabis use disorder: Exploring a treatment as needed model with 34-month follow-up.
Cannabis use disorder
Continuing care
Long-term follow-up
Marijuana treatment
Journal
Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
04
02
2020
revised:
15
05
2020
accepted:
13
07
2020
entrez:
20
8
2020
pubmed:
20
8
2020
medline:
29
7
2021
Statut:
ppublish
Résumé
Research has demonstrated that motivational enhancement (MET) and cognitive behavioral therapy (CBT) are some of the most effective interventions for adults with cannabis use disorder (CUD). As few as two sessions of combined MET and CBT has produced abstinence and reductions in cannabis use greater than delayed treatment controls. Despite their efficacy, outcomes in previous studies yielded abstinence rates from cannabis in the range of 20-30% at follow-ups of 6 to 12 months, and CUD remained a chronic condition for many. Additional models of providing treatment "as needed" (PRN), rather than as a single fixed-dose, are necessary to meet the different needs of adults with CUD and reengage those who do not respond to treatment initially or who relapse later. In the current study, 87 adults who met DSM-IV criteria for cannabis dependence were randomly assigned to receive either a fixed-dose of nine sessions of MET/CBT or to a PRN condition that provided a smaller initial dose of treatment, but allowed repeated access to treatment for 28 months. Cannabis use and associated problems were assessed every six months throughout a 34-month period. More than one-third of participants in the PRN condition accessed additional treatment episodes, but the total number of treatment sessions that participants utilized was comparable across conditions. Both treatments yielded significant reductions in cannabis use and associated problems at each follow-up. Contrary to hypotheses, the PRN condition did not yield better outcomes at the longer-term follow-ups. The fixed-dose condition produced greater rates of abstinence at the first follow-up, but otherwise there were no between group differences in outcomes. Future studies should test active approaches to reengaging participants with treatment when initial outcomes are less than optimal.
Identifiants
pubmed: 32811637
pii: S0740-5472(20)30344-5
doi: 10.1016/j.jsat.2020.108088
pmc: PMC7478338
mid: NIHMS1616479
pii:
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
108088Subventions
Organisme : NIDA NIH HHS
ID : R01 DA014050
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Références
Addiction. 2002 Dec;97 Suppl 1:109-24
pubmed: 12460133
Eval Program Plann. 2003 Aug;26(3):339-352
pubmed: 30034059
J Consult Clin Psychol. 2000 Oct;68(5):898-908
pubmed: 11068976
J Consult Clin Psychol. 2000 Dec;68(6):1051-61
pubmed: 11142539
J Consult Clin Psychol. 1983 Jun;51(3):390-5
pubmed: 6863699
Addiction. 2009 Jun;104(6):959-71
pubmed: 19344441
Exp Clin Psychopharmacol. 1998 Nov;6(4):419-26
pubmed: 9861556
J Consult Clin Psychol. 2004 Jun;72(3):455-66
pubmed: 15279529
J Subst Abuse Treat. 2001 Sep;21(2):55-64; discussion 65-6
pubmed: 11551733
Addiction. 2002 Dec;97 Suppl 1:135-42
pubmed: 12460135
J Subst Abuse Treat. 2015 Sep;56:11-5
pubmed: 25922136
Psychol Methods. 2002 Jun;7(2):147-77
pubmed: 12090408
Addict Behav. 2018 Jan;76:52-60
pubmed: 28755613
J Consult Clin Psychol. 1993 Dec;61(6):1100-4
pubmed: 8113490
Cochrane Database Syst Rev. 2016 May 05;(5):CD005336
pubmed: 27149547
Addiction. 2015 Jan;110(1):19-35
pubmed: 25287883
JAMA Psychiatry. 2015 Dec;72(12):1235-42
pubmed: 26502112